The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Conversion to resection post radioembolization in patients with HCC: recommendations from a multidisciplinary working group
HPB (Oxford). 2022 Jul;24(7):1007-1018. doi: 10.1016/j.hpb.2021.12.013.Epub 2021 Dec 25.
1University of Utah, Salt Lake City, UT, USA. Electronic address: Talia.Baker@hsc.utah.edu.
2Mount Sinai Hospital, New York, NY, USA.
3Intermountain Health, Salt Lake City, UT, USA.
4Medical College of Wisconsin, Milwaukee, WI, USA.
5Piedmont Hospital, Atlanta, GA, USA.
6Centre Eugène Marquis, Rennes University, France.
7University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
8Northwestern Memorial Hospital, Chicago, IL, USA.
Abstract
Background: Transarterial radioembolization (TARE) with yttrium-90 (90Y) glass microspheres is an efficacious option for converting appropriately selected patients with borderline-resectable hepatocellular carcinoma (HCC) to surgical candidacy.
Methods: In 2018 and 2019, a diverse multidisciplinary group of surgical and interventional experts with experience using 90Y for downstaging and bridging to liver transplant convened to review peer-reviewed literature and personal experience in the use of 90Y to convert borderline resectable liver cancer patients to surgical candidacy. The working group included surgical oncologists specializing in liver cancer, liver transplant surgeons with experience in complex hepatobiliary surgery, and interventional radiologists with experience using 90Y.
Results: This document presents expert recommendations based upon the group's experience and consensus.
Conclusions: By combining related evidence from the literature with expert experiences with TARE in surgical candidates, these recommendations aim to demonstrate the safety, efficacy, and feasibility of TARE in converting borderline-resectable patients to surgical options. The document also addresses the concerns about potential complications associated with TARE during the surgical intervention.